Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study
Journal of Thrombosis and Haemostasis · 2024-12 · 22 (12) · 3521-3531
DOI: 10.1016/j.jtha.2024.08.016 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024-12. Verfasst von Allen B Repp und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA; Department of Medicine, University of Verm…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Anticoagulants, Inpatients, Hospitalization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, NHLBI NIH HHS, National Heart Lung and Blood Institute.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
BACKGROUND: Although guidelines recommend risk assessment for hospital-acquired venous thromboembolism (HA-VTE) to inform prophylaxis decisions, studies demonstrate inappropriate utilization of pharmacoprophylaxis in hospitalized medical patients. Predictors of pharmacoprophylaxis initiation in medical inpatients remain largely unknown. OBJECTIVES: To determine factors associated with HA-VTE pharmacoprophylaxis initiation in adults hospitalized on medical services. METHODS: We performed a cohort study using electronic health record data from adult patients hospitalized on medical services at 4 academic medical centers between 2016 and 2019. Main measures were candidate predictors of HA-VTE pharmacoprophylaxis initiation, including known HA-VTE risk factors, predicted HA-VTE risk, and bleeding diagnoses present on admission. RESULTS: Among 111 550 admissions not on intermediate or full-dose anticoagulation, 48 520 (43.5%) received HA-VTE pharmacoprophylaxis on the day of or the day after admission. After adjustment for age, sex, race/ethnicity, and study site, the strongest clinical predictors of HA-VTE pharmacoprophylaxis initiation were malnutrition and chronic obstructive pulmonary disease. Thrombocytopenia and history of gastrointestinal bleeding were associated with decreased odds of HA-VTE pharmacoprophylaxis initiation. Patients in the highest 2 tertiles of predicted HA-VTE risk were less likely to receive HA-VTE pharmacoprophylaxis than patients in the lowest (first) tertile (OR, 0.84; 95% CI, 0.81-0.86 for the second tertile; OR, 0.95; 95% CI, 0.92-0.98 for the third tertile). CONCLUSION: Among patients not already receiving anticoagulants, HA-VTE pharmacoprophylaxis initiation during the first 2 hospital days was lower in patients with a higher predicted HA-VTE risk and those with risk factors for bleeding. Reasons for not initiating pharmacoprophylaxis in those with a higher predicted HA-VTE risk could not be assessed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA; Department of Medicine, University of Vermont Medical Center, Burlington, Vermont, USA. Electronic address: alle…
- Department of Medical Biostatistics, University of Vermont, Burlington, Vermont, USA.
- Department of Pathology & Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
- Department of Medicine, Hennepin Healthcare & Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA.
- Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.
- Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Förderung
- Intramural CDC HHS
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- Cancer Prevention and Research Institute of Texas
- University of Vermont
- Baylor College of Medicine
- Centers for Disease Control and Prevention
- National Institutes of Health
Zitieren
APA
Repp, A. B., Sparks, A. D., Wilkinson, K., Roetker, N. S., Schaefer, J. K., Li, A., McClure, L. A., Terrell, D. R., Ferraris, A., Adamski, A., Smith, N. L., & Zakai, N. A. (2024). Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study. Journal of Thrombosis and Haemostasis, 22(12), 3521-3531. https://doi.org/10.1016/j.jtha.2024.08.016
Vancouver
Repp AB, Sparks AD, Wilkinson K, Roetker NS, Schaefer JK, Li A, et al. Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study. Journal of Thrombosis and Haemostasis. 2024;22(12):3521-3531. doi:10.1016/j.jtha.2024.08.016
BibTeX
@article{Repp2024,
author = {Repp, Allen B and Sparks, Andrew D and Wilkinson, Katherine and Roetker, Nicholas S and Schaefer, Jordan K and Li, Ang and McClure, Leslie A and Terrell, Deirdra R and Ferraris, Augusto and Adamski, Alys and Smith, Nicholas L and Zakai, Neil A},
title = {Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
volume = {22},
number = {12},
pages = {3521--3531},
doi = {10.1016/j.jtha.2024.08.016}
}
EUVIMED